Login

Balance sheets

In millions of USD, except per-share amounts
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
ASSETS
Current assets:
Cash
Cash - restricted
Prepaid expenses
Due from Sponsor
Total current assets
Forward purchase asset
Cash held in Trust Account
Total assets
LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable and accrued expenses
Accrued offering costs
Note payable - Sponsor
Total current liabilities
Deferred underwriting compensation
Forward purchase liability
Derivative warrant liabilities
Total liabilities
Class A common stock subject to possible redemption (3,103,541 shares at approximately $10.65 and $10.63 per share redemption value as of March 31, 2024 and December 31, 2023, respectively)
Stockholders' deficit:
Common stock
Class A common stock
Class A common stock not subject to redemption
Total class A common stock
Class B common stock
Additional paid-in capital
Private Placement Warrants
Total additional paid-in capital
Accumulated deficit
Class A common stock
Class B common stock
Total stockholders' deficit
Total liabilities, common stock subject to possible redemption and stockholders' deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support